Efficacy and Safety of Fexuprazan Versus Esomeprazole for Gastroesophageal Reflux Disease-Related Chronic Cough: A Randomized, Double-Blind, Active-Controlled Exploratory Trial
These findings support the potential of P-CABs as a promising alternative to PPIs for patients with chronic cough requiring acid-suppressive therapy.
Authors
- Min-Gyu Kang (ORCID: https://orcid.org/0000-0003-1443-0135)
- Eun‐Jung Jo (ORCID: https://orcid.org/0000-0003-3712-6216)
- Woo‐Jung Song (ORCID: https://orcid.org/0000-0002-4630-9922)
- Sae-Hoon Kim
- Noeul Kang (ORCID: https://orcid.org/0000-0003-0925-3891)
- Sung‐Yoon Kang (ORCID: https://orcid.org/0000-0001-5505-3028)
- Jiho Lee (ORCID: https://orcid.org/0000-0001-8027-835X)
- Byung‐Jae Lee (ORCID: https://orcid.org/0000-0001-6940-0836)
- Seungeun Lee (ORCID: https://orcid.org/0000-0002-2951-7869)
- Joon-Woo Bahn
Institutions
- Yonsei University (KR)
- Asan Medical Center (KR)
- Samsung Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- University of Ulsan (KR)
- Gachon University Gil Medical Center (KR)
- Pusan National University Yangsan Hospital (KR)
- Chungbuk National University Hospital (KR)
- Pusan National University (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Lung
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1007/s00408-025-00815-5
- Citations
- 6
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 9.11
Funders
- Daewoong Pharmaceutical Company